These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3981498)

  • 21. [The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate].
    Spahn H; Altmayer P; Cattarius-Korb S; Krüger B; Lang E; Mutschler E; Sörgel F
    Arzneimittelforschung; 1985; 35(6):973-6. PubMed ID: 4026924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrations of lonazolac in serum and synovial fluid of patients with inflammatory or degenerate joint disease.
    Mayrhofer F; Thumb N
    Int J Clin Pharmacol Res; 1984; 4(6):415-7. PubMed ID: 6533085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and protein binding of salicylate metabolites in rats.
    Morris ME
    Drug Metab Dispos; 1990; 18(5):809-11. PubMed ID: 1981740
    [No Abstract]   [Full Text] [Related]  

  • 24. Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
    Grace EM; Mewa AA; Sweeney GD; Rosenfeld JM; Darke AC; Buchanan WW
    J Rheumatol; 1986 Dec; 13(6):1119-21. PubMed ID: 3560102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of salicylate, gentisic acid and salicyluric acid in human urine by capillary electrophoresis with laser-induced fluorescence detection.
    Zaugg S; Zhang X; Sweedler J; Thormann W
    J Chromatogr B Biomed Sci Appl; 2001 Mar; 752(1):17-31. PubMed ID: 11254191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous high-performance liquid chromatographic determination of salicylates in whole blood, plasma and isolated erythrocytes.
    Klimes J; Sochor J; Zahradnícek M; Sedlácek J
    J Chromatogr; 1992 Dec; 584(2):221-8. PubMed ID: 1484107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin-initiated hydroxyl radical formation: characterization by enhanced salicylate hydroxylation.
    Kim PM; Wells PG
    Mol Pharmacol; 1996 Jan; 49(1):172-81. PubMed ID: 8569704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in urine.
    Cham BE; Bochner F; Imhoff DM; Johns D; Rowland M
    Clin Chem; 1980 Jan; 26(1):111-4. PubMed ID: 7356541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antacids on salicylate kinetics.
    Shastri RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):480-4. PubMed ID: 4055159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
    Day RO; Francis H; Vial J; Geisslinger G; Williams KM
    J Rheumatol; 1995 Dec; 22(12):2295-303. PubMed ID: 8835565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinetics of salicylates from the blood to the articular fluid].
    Soren A
    Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):165-9. PubMed ID: 653293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gentisate, a salicylate metabolite with antioxidant properties.
    Cleland LG; Whitehouse MW; Betts WH
    Drugs Exp Clin Res; 1985; 11(8):463-7. PubMed ID: 3879751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in salicylic acid metabolism in Nigerian subjects.
    Emudianughe TS; Oduleye SO; Ebadan EE; Eneji SD
    Xenobiotica; 1986 Feb; 16(2):177-9. PubMed ID: 3962337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of acetyl salicylic acid and its metabolites in children suffering from autoimmune diseases.
    Juárez Olguín H; Flores Pérez J; Lares Asseff I; Loredo Abdalá A; Carbajal Rodríguez L
    Biopharm Drug Dispos; 2004 Jan; 25(1):1-7. PubMed ID: 14716747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppressive effect of post- or pre-treatment of aspirin metabolite on mitomycin C-induced genotoxicity using the somatic mutation and recombination test in Drosophila melanogaster.
    Niikawa M; Shin S; Nagase H
    Biomed Pharmacother; 2007; 61(2-3):113-9. PubMed ID: 17275250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transdermal salicylate absorption following epidermal application of an analgesic / antiphlogistic ointment and gel formulation (author's transl)].
    Hüther KJ; Hiereth H; Messer W
    Arzneimittelforschung; 1982; 32(1):69-72. PubMed ID: 7199343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal clearance of salicylic acid and salicyluric acid in the rat and in the isolated perfused rat kidney.
    Bekersky I; Fishman L; Kaplan SA; Colburn WA
    J Pharmacol Exp Ther; 1980 Feb; 212(2):309-14. PubMed ID: 7351644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of phenylbutazone in synovial fluid.
    Farr M; Willis JV
    J Int Med Res; 1977; 5 Suppl 2():26-9. PubMed ID: 913871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography.
    Liu JH; Smith PC
    J Chromatogr B Biomed Appl; 1996 Jan; 675(1):61-70. PubMed ID: 8634769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.